Teesdale-Spittle PH - Search Results

1

Characterizing the laulimalide-peloruside binding site using site-directed mutagenesis of TUB2 in S. cerevisiae.

Hanna R, Maass DR, Atkinson PH, Northcote PT, Teesdale-Spittle PH, Bellows DS, Miller JH. Hanna R, et al. Mol Biosyst. 2014 Jan;10(1):110-6. doi: 10.1039/c3mb70380k. Mol Biosyst. 2014. PMID: 24161989

2

βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.

Kanakkanthara A, Rowe MR, Field JJ, Northcote PT, Teesdale-Spittle PH, Miller JH. Kanakkanthara A, et al. Cancer Lett. 2015 Sep 1;365(2):251-60. doi: 10.1016/j.canlet.2015.06.001. Epub 2015 Jun 4. Cancer Lett. 2015. PMID: 26052091

3

Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.

Gaitanos TN, Buey RM, Díaz JF, Northcote PT, Teesdale-Spittle P, Andreu JM, Miller JH. Gaitanos TN, et al. Cancer Res. 2004 Aug 1;64(15):5063-7. doi: 10.1158/0008-5472.CAN-04-0771. Cancer Res. 2004. PMID: 15289305

4

The protein synthesis inhibitors mycalamides A and E have limited susceptibility toward the drug efflux network.

Venturi V, Davies C, Singh AJ, Matthews JH, Bellows DS, Northcote PT, Keyzers RA, Teesdale-Spittle PH. Venturi V, et al. J Biochem Mol Toxicol. 2012 Mar;26(3):94-100. doi: 10.1002/jbt.20414. Epub 2011 Dec 8. J Biochem Mol Toxicol. 2012. PMID: 22162108

5

The cellular target specificity of pateamine A.

Matthews JH, Maass DR, Northcote PT, Atkinson PH, Teesdale-Spittle PH. Matthews JH, et al. Z Naturforsch C J Biosci. 2013 Sep-Oct;68(9-10):406-15. doi: 10.1515/znc-2013-9-1008. Z Naturforsch C J Biosci. 2013. PMID: 24459774 Free article.

6

Characterisation of the biological response of Saccharomyces cerevisiae to the loss of an allele of the eukaryotic initiation factor 4A.

Venturi V, Little R, Bircham PW, Rodigheri Brito J, Atkinson PH, Maass DR, Teesdale-Spittle PH. Venturi V, et al. Among authors: teesdale spittle ph. Biochem Biophys Res Commun. 2018 Feb 19;496(4):1082-1087. doi: 10.1016/j.bbrc.2018.01.137. Epub 2018 Feb 1. Biochem Biophys Res Commun. 2018. PMID: 29397069

7

Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.

Kanakkanthara A, Teesdale-Spittle PH, Miller JH. Kanakkanthara A, et al. Anticancer Agents Med Chem. 2013 Jan;13(1):147-58. Anticancer Agents Med Chem. 2013. PMID: 22583426 Review.

8

Structure-activity studies of the pelorusides: new congeners and semi-synthetic analogues.

Singh AJ, Razzak M, Teesdale-Spittle P, Gaitanos TN, Wilmes A, Paterson I, Goodman JM, Miller JH, Northcote PT. Singh AJ, et al. Org Biomol Chem. 2011 Jun 21;9(12):4456-66. doi: 10.1039/c0ob01127d. Epub 2011 Apr 21. Org Biomol Chem. 2011. PMID: 21512693

9

Heptanosides from galactose-derived oxepenes via stereoselective addition reactions.

Batchelor R, Harvey JE, Northcote PT, Teesdale-Spittle P, Hoberg JO. Batchelor R, et al. J Org Chem. 2009 Oct 16;74(20):7627-32. doi: 10.1021/jo901706e. J Org Chem. 2009. PMID: 19754106

10

Synthesis of Bioactive Side-Chain Analogues of TAN-2483B.

Somarathne KK, McCone JAJ, Brackovic A, Rivera JLP, Fulton JR, Russell E, Field JJ, Orme CL, Stirrat HL, Riesterer J, Teesdale-Spittle PH, Miller JH, Harvey JE. Somarathne KK, et al. Among authors: teesdale spittle ph. Chem Asian J. 2019 Apr 15;14(8):1230-1237. doi: 10.1002/asia.201801767. Epub 2019 Jan 29. Chem Asian J. 2019. PMID: 30618187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters